These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26028417)

  • 21. Inhibition of mitochondrial respiration by furancarboxylic acid accumulated in uremic serum in its albumin-bound and non-dialyzable form.
    Niwa T; Aiuchi T; Nakaya K; Emoto Y; Miyazaki T; Maeda K
    Clin Nephrol; 1993 Feb; 39(2):92-6. PubMed ID: 8448924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of serum in hemodialysis patients on the expression of intestinal and hepatic transporters for the excretion of pravastatin.
    Tsujimoto M; Hatozaki D; Shima D; Yokota H; Furukubo T; Izumi S; Yamakawa T; Minegaki T; Nishiguchi K
    Ther Apher Dial; 2012 Dec; 16(6):580-7. PubMed ID: 23190519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of decreased vitamin D and accumulated uremic toxin on human CYP3A4 activity in patients with end-stage renal disease.
    Tsujimoto M; Nagano Y; Hosoda S; Shiraishi A; Miyoshi A; Hiraoka S; Furukubo T; Izumi S; Yamakawa T; Minegaki T; Nishiguchi K
    Toxins (Basel); 2013 Aug; 5(8):1475-85. PubMed ID: 23965431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Displacement by anionic drugs of endogenous ligands bound to albumin in uremic serum.
    Mabuchi H; Nakahashi H
    Ther Drug Monit; 1988; 10(3):261-4. PubMed ID: 3140432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel UPLC-MS-MS method for simultaneous determination of seven uremic retention toxins with cardiovascular relevance in chronic kidney disease patients.
    Boelaert J; Lynen F; Glorieux G; Eloot S; Van Landschoot M; Waterloos MA; Sandra P; Vanholder R
    Anal Bioanal Chem; 2013 Feb; 405(6):1937-47. PubMed ID: 23307120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring binding characteristics and the related competition of different protein-bound uremic toxins.
    Deltombe O; de Loor H; Glorieux G; Dhondt A; Van Biesen W; Meijers B; Eloot S
    Biochimie; 2017 Aug; 139():20-26. PubMed ID: 28528271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A major inhibitor of phenytoin binding to serum protein in uremia.
    Mabuchi H; Nakahashi H
    Nephron; 1988; 48(4):310-4. PubMed ID: 3362278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Organic acids and the uremic syndrome: protein metabolite hypothesis in the progression of chronic renal failure.
    Niwa T
    Semin Nephrol; 1996 May; 16(3):167-82. PubMed ID: 8734460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic clearance, but not gut availability, of erythromycin is altered in patients with end-stage renal disease.
    Sun H; Frassetto LA; Huang Y; Benet LZ
    Clin Pharmacol Ther; 2010 Apr; 87(4):465-72. PubMed ID: 20090676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cooperative inhibitory effects of uremic toxins and other serum components on OATP1B1-mediated transport of SN-38.
    Katsube Y; Tsujimoto M; Koide H; Ochiai M; Hojyo A; Ogawa K; Kambara K; Torii N; Shima D; Furukubo T; Izumi S; Yamakawa T; Minegaki T; Nishiguchi K
    Cancer Chemother Pharmacol; 2017 Apr; 79(4):783-789. PubMed ID: 28314987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Albumin is the main plasma binding protein for indoxyl sulfate and p-cresyl sulfate.
    Viaene L; Annaert P; de Loor H; Poesen R; Evenepoel P; Meijers B
    Biopharm Drug Dispos; 2013 Apr; 34(3):165-75. PubMed ID: 23300093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Underestimation of serum albumin by the bromcresol purple method and a major endogenous ligand in uremia.
    Mabuchi H; Nakahashi H
    Clin Chim Acta; 1987 Jul; 167(1):89-96. PubMed ID: 3665090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of uremic toxin transport by organic anion transporters in the kidney.
    Deguchi T; Kusuhara H; Takadate A; Endou H; Otagiri M; Sugiyama Y
    Kidney Int; 2004 Jan; 65(1):162-74. PubMed ID: 14675047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis.
    Fagugli RM; De Smet R; Buoncristiani U; Lameire N; Vanholder R
    Am J Kidney Dis; 2002 Aug; 40(2):339-47. PubMed ID: 12148107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between Saliva Levels and Serum Levels of Free Uremic Toxins in Healthy Volunteers.
    Fabresse N; Larabi IA; Abe E; Lamy E; Rigothier C; Massy ZA; Alvarez JC
    Toxins (Basel); 2023 Feb; 15(2):. PubMed ID: 36828466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous quantification of coproporphyrin-I and 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid in human plasma using ultra-high performance liquid chromatography coupled to tandem mass spectrometry.
    Suzuki Y; Sasamoto Y; Yoshijima C; Tanaka R; Ono H; Ando T; Shin T; Mimata H; Itoh H; Ohno K
    J Pharm Biomed Anal; 2020 May; 184():113202. PubMed ID: 32114159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, a major endogenous ligand substance in uremic serum, by high-performance liquid chromatography with ultraviolet detection.
    Mabuchi H; Nakahashi H
    J Chromatogr; 1987 Mar; 415(1):110-7. PubMed ID: 3584344
    [No Abstract]   [Full Text] [Related]  

  • 38. Renal disposition of a furan dicarboxylic acid and other uremic toxins in the rat.
    Tsutsumi Y; Deguchi T; Takano M; Takadate A; Lindup WE; Otagiri M
    J Pharmacol Exp Ther; 2002 Nov; 303(2):880-7. PubMed ID: 12388676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of furancarboxylic acid, a candidate for uremic toxin, in human serum, hair, and sweat, and analysis of pharmacological actions in vitro.
    Sassa T; Matsuno H; Niwa M; Kozawa O; Takeda N; Niwa T; Kumada T; Uematsu T
    Arch Toxicol; 2000 Feb; 73(12):649-54. PubMed ID: 10741476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of uremic serum and uremic toxins on hepatic uptake of digoxin.
    Tsujimoto M; Kinoshita Y; Hirata S; Otagiri M; Ohtani H; Sawada Y
    Ther Drug Monit; 2008 Oct; 30(5):576-82. PubMed ID: 18708994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.